C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692)
01/1998
01/07/1998	EP0815084A1 Lactam-containing hydroxamic acid derivatives, their preparation and their use as inhibitors of matrix metalloprotease
01/07/1998	EP0814849A1 Magnetically labeled chemoattractants as targeted contrast agents in the nmr imaging of living tissues
01/07/1998	EP0716609A4 METHODS AND COMPOSITIONS FOR STIMULATING AND INHIBITING TGF--g(b) ACTIVITY
01/07/1998	EP0565396B1 1-[2-(arylsulfonylamino)-1-oxoethyl]piperidine derivatives, their preparation and use in therapy
01/07/1998	CN1169731A Tachykinin antagonists
01/07/1998	CN1169730A Aromatic heterocyclic derivatives as enzyme inhibitors
01/06/1998	US5705693 Cationic lipids
01/06/1998	US5705686 Inhibition of farnesyl transferase
12/1997
12/31/1997	WO1997049723A1 Cationic lipids for delivery of nucleic acid to cells
12/31/1997	WO1997049722A1 Depsipeptides and drugs containing the same as the active ingredient
12/31/1997	WO1997049430A1 Immunotherapy by modulation of antigen presentation
12/31/1997	WO1997049419A1 Ophthalmic drug compositions
12/31/1997	WO1997049404A1 Anticoagulant agents
12/31/1997	CA2259159A1 Depsipeptides and drugs containing the same as the active ingredient
12/31/1997	CA2258915A1 Anticoagulant agents
12/30/1997	US5703241 Inhibitor of farnesyl-protein transferase
12/30/1997	US5703208 3-amino-2-oxo-1-piperidineacetic derivatives as enzyme inhibitors
12/30/1997	US5703106 Treating various cardiovascular, urogenital, brain disorders
12/30/1997	US5703076 Retroviral protease inhibitors
12/30/1997	US5703073 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
12/30/1997	US5703050 Inhibit platelet aggregation, metastasis of carcinoma cells, osteoclast binding to bone surface
12/30/1997	CA2142707C Benzo-fused lactams promote release of growth hormone
12/29/1997	EP0813868A2 Retroviral protease inhibitors
12/29/1997	EP0813867A2 Retroviral protease inhibitors
12/29/1997	EP0813543A1 Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/29/1997	EP0813542A1 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
12/24/1997	WO1997048688A1 Thiadiazole amide mmp inhibitors
12/24/1997	WO1997048408A2 Method for the prevention and treatment of mastitis
12/24/1997	CN1168695A Inhibitor of stem cell proliferation and uses thereof
12/24/1997	CN1168673A New dipeptide p-amidinobenzylamides with N-terminal sulfonyl or aminosulfonyl radicals
12/24/1997	CN1168635A New antithrombotic formulation, process for its manufacturing, and use thereof
12/24/1997	CN1168633A Boronic ester and acid compounds, synthesis and uses
12/24/1997	CA2251779A1 Method for the prevention and treatment of mastitis
12/23/1997	US5700922 PNA-DNA-PNA chimeric macromolecules
12/23/1997	US5700910 N-acyl-S-(2-hydroxyalkyl) cysteines, their preparation and their use as intermediates for the preparation of synthetic immuno-adjuvants and synthetic vaccines
12/23/1997	US5700827 Amino acid derivatives, processes for the manufacture thereof and pharmaceutical compositions (II) containing these compounds
12/23/1997	US5700780 Oligopeptide viricides; ribonucleotide reductase enzyme inhibitor
12/23/1997	US5700444 Metallopeptide for drug delivery, diagnosis, treating infections, inflammations, diseases
12/23/1997	CA1339595C New antibiotics of the mureidomycin group, their preparation, and their therapeutic use
12/18/1997	WO1997047329A2 Radiopharmaceutical compositions capable of localizing at sites of thrombus
12/18/1997	CA2257856A1 Radiopharmaceutical compositions capable of localizing at sites of thrombus
12/17/1997	EP0812857A1 Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof
12/17/1997	EP0812839A1 Irreversible HIV protease inhibitors, compositions containing same and process for the preparation thereof
12/17/1997	EP0812327A1 Protein phosphatase inhibitor
12/17/1997	EP0812212A1 Compositions for the delivery of antigens
12/17/1997	EP0812205A1 Antithrombotic azacycloalkylalkanoyl peptides and pseudopeptides
12/17/1997	EP0812203A1 Inhibitors of geranylgeranyl-protein transferase
12/17/1997	EP0656902B1 Peptide lung surfactants and therapeutic combinations
12/17/1997	EP0655068B1 Process for synthesizing a beta-aminoalkylboronic acid and ester thereof
12/16/1997	US5698673 Peptides having anti-melittin activity
12/16/1997	US5698569 Viricide
12/16/1997	US5698523 Acylated enol derivatives as prodrugs of elastase inhibitors
12/11/1997	WO1997046577A1 New amino acid derivatives and their use as thrombin inhibitors
12/11/1997	WO1997046576A1 Anticoagulant peptidyl-arginine aldehyde derivatives
12/11/1997	WO1997046551A1 Substituted quinolylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/11/1997	WO1997046259A2 Chimeric toxin for targeted therapy
12/11/1997	WO1997046252A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
12/11/1997	WO1997046207A2 Aromatic heterocyclic derivatives as enzyme inhibitors
12/11/1997	WO1997041443A3 Method for screening compounds
12/11/1997	DE19721290A1 ACE-inhibiting substituted alanyl-derivatives of e.g. proline preparation
12/11/1997	CA2257174A1 Growth hormone component and bone anti-resorptive agent in cyclic (coherence) treatment of osteoporosis
12/11/1997	CA2255625A1 New amino acid derivatives and their use as thrombin inhibitors
12/10/1997	EP0811072A1 Transgenic animals as model of psoriasis
12/10/1997	EP0811012A1 Method of producing l-aspartyl-d-alanine-n-(thiethane-3-yl)-amides
12/10/1997	EP0810870A1 Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof
12/10/1997	EP0659193B1 Platelet aggregation inhibitors
12/09/1997	US5696270 Intermediate for making retroviral protease inhibiting compounds
12/09/1997	US5696249 Nucleic acid ligands
12/09/1997	US5696231 N-substituted glycine derivatives as enzyme inhibitors
12/09/1997	US5696159 Lactone compounds for treating patients with precancerous lesions
12/09/1997	US5696147 Inhibition of angiogenesis by synthetic matrix metalloprotease inhibitors
12/09/1997	US5696134 Irreversible HIV protease inhibitors, intermediates, compositions and processes for the preparation thereof
12/09/1997	US5695952 Method for producing Leu13 !motilin
12/04/1997	WO1997045409A1 Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
12/04/1997	WO1997045117A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
12/04/1997	WO1997045107A1 Remedies for brain diseases
12/04/1997	WO1997040065A3 Substrates and inhibitors of proteolytic enzymes
12/04/1997	CA2256669A1 Prodrugs of thalidomide and methods for using same as modulators of t-cell function
12/03/1997	EP0810209A2 Alpha - and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/03/1997	EP0810208A2 N-substituted Hydroxyethylamino sulfamic acid derivatives useful as retroviral protease inhibitors
12/03/1997	EP0809651A1 Thrombin inhibitors
12/03/1997	EP0809650A1 Serine protease inhibitors
12/03/1997	EP0627939B1 Conjugates of biotin and deferoxamine for radioimmunoimaging and radioimmunotherapy
12/03/1997	EP0533838B1 Nucleic acid ligands
12/03/1997	CN1166490A Prep of novel mercaptoacetylamide derivatives
12/03/1997	CN1036590C Process for preparation of mercaptoacetylamide derivatives
12/02/1997	US5693858 Organic salts of N,N'-diacetyl cystine
12/02/1997	US5693815 Peptides
12/02/1997	US5693633 Angiotensin II antagonists
12/02/1997	US5693617 Inhibitors of the 26s proteolytic complex and the 20s proteasome contained therein
12/02/1997	US5693612 Used for prophylaxis and treatment of disorders of the circulation, bones and in tumor therapy, and as antimicrobial and antiviral active compounds
12/02/1997	US5693485 Enzymatic coupling reaction of N-protected-L-aspartic acid and phenylalanine methyl ester
12/02/1997	CA2057734C Oxidized-type glutathione alkyl ester
11/1997
11/27/1997	WO1997044481A1 Compositions and methods for screening antimicrobials
11/27/1997	WO1997044479A1 Novel antitumor compounds and process for producing the same
11/27/1997	WO1997044350A1 Inhibitors of protein farnesyl transferase
11/27/1997	WO1997044052A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	CA2258698A1 Immunomodulating compounds comprising d-isomers of amino acids
11/27/1997	CA2253934A1 Inhibitors of protein farnesyl transferase
11/26/1997	EP0808458A1 Dioxetane compounds for the chemiluminescent detection of proteases, methods of use and kits therefore

1 ... 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 ... 307